Table 1 Patient and tumor clinicopathological characteristics of 601 samples
From: A 25-gene classifier predicts overall survival in resectable pancreatic cancer
Characteristics | All (n = 601) |
|---|---|
Age at diagnosis, years | |
≤ 60 | 118 (32%) |
> 60 | 246 (68%) |
Sex | |
Female | 170 (46%) |
Male | 197 (54%) |
AJCC Stage | |
1 | 62 (12%) |
2 | 431 (84%) |
3 | 10 (2%) |
4 | 12 (2%) |
Pathological type | |
Ductal | 537 (98%) |
Othera | 11 (2%) |
Pathological grade | |
1 | 33 (12%) |
2 | 154 (55%) |
3 | 91 (32%) |
4 | 2 (1%) |
Pathological tumor size (pT) | |
pT1 | 18 (5%) |
pT2 | 62 (16%) |
pT3 | 302 (77%) |
pT4 | 11 (3%) |
Pathological lymph node status (pN) | |
Negative | 141 (31%) |
Positive | 310 (69%) |
Collisson subtypes | |
Classical | 234 (39%) |
Exocrine-like | 211 (35%) |
Quasi-mesenchymal | 156 (26%) |
Moffitt subtypes, ‘type’ | |
Basal-like | 232 (39%) |
Classical | 369 (61%) |
Bailey subtypes | |
ADEX | 140 (23%) |
Immunogenic | 104 (17%) |
Pancreatic progenitor | 142 (24%) |
Squamous | 215 (36%) |
Deceased | 354 (59%) |
2-year OS (95% CI) | 40% (36–45) |
Median OS, months (range) | 20 (1–156.4) |